| |
| |
|
| Insider
Information: |
Wentworth Kerry |
| Relationship: |
Chief Regulatory Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
57,410 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,410 |
|
|
| Total
Value |
$25,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -91.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agenus Inc |
AGEN |
VP, Clinical, Reg & Qual |
2014-02-26 |
57,410 |
|
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Chief Regulatory Officer |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2018-06-20 |
4 |
A |
$21.22 |
$3,629 |
D/D |
171 |
12,478 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2018-10-08 |
4/A |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
14,876 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2018-10-08 |
4 |
D |
$18.60 |
$18,637 |
D/D |
(1,002) |
11,476 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2019-10-07 |
4 |
D |
$13.98 |
$14,008 |
D/D |
(1,002) |
53,394 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2019-01-03 |
4 |
AS |
$12.36 |
$7,688 |
D/D |
(622) |
11,207 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-01-05 |
4 |
S |
$11.13 |
$76,007 |
D/D |
(6,829) |
113,767 |
0 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2020-06-22 |
4 |
A |
$10.83 |
$3,996 |
D/D |
369 |
81,430 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2019-06-21 |
4 |
A |
$9.81 |
$3,816 |
D/D |
389 |
50,996 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$51,000 |
I/I |
(6,000) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$1,197,166 |
D/D |
(140,843) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-06-21 |
4 |
A |
$7.78 |
$4,193 |
D/D |
539 |
144,306 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-04-26 |
4 |
A |
$6.43 |
$4,469 |
D/D |
695 |
45,065 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-03-15 |
4 |
A |
$5.31 |
$32,269 |
D/D |
6,077 |
44,370 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-19 |
4 |
A |
$5.26 |
$74,445 |
D/D |
14,153 |
59,218 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-21 |
4 |
D |
$5.05 |
$74,659 |
D/D |
(14,784) |
30,283 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg & Qual |
• – – |
2014-02-26 |
4 |
AS |
$5.00 |
$25,000 |
D/D |
(5,000) |
57,410 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-06-20 |
4 |
D |
$4.99 |
$70,613 |
D/D |
(14,151) |
45,067 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Req & Quality |
• – – |
2012-07-26 |
4 |
A |
$4.61 |
$3,199 |
D/D |
694 |
30,977 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Clin, Reg & Quality |
• – – |
2012-10-26 |
4 |
A |
$4.42 |
$3,072 |
D/D |
695 |
36,716 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2013-01-28 |
4 |
A |
$4.35 |
$3,019 |
D/D |
694 |
37,410 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-01-26 |
4 |
A |
$2.76 |
$1,915 |
D/D |
694 |
38,293 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg & Quality |
• – – |
2011-10-26 |
4 |
A |
$2.70 |
$1,877 |
D/D |
695 |
35,481 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2009-09-10 |
4 |
A |
$2.40 |
$12,000 |
D/D |
5,000 |
107,799 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2009-09-11 |
4 |
S |
$2.32 |
$3,176 |
D/D |
(1,367) |
106,432 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
• – – |
2008-03-24 |
4 |
D |
$2.28 |
$1,243 |
D/D |
(545) |
7,007 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
